OCS Oculis Holding AG
CATEGORY BREAKDOWN
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
> 50% strong
Gross Margin
Revenue retained after direct costs
> 50% strong
Cash Runway
Months of cash at current burn rate
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
< 25% strong
Price / Sales
Market cap relative to trailing revenue
< 3x strong
Rule of 40
Growth rate plus operating margin
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
< 5% ideal
5 more metrics available
Unlock all 8 metrics, score history, watchlist, and side-by-side comparison.
Try Free for 30 DaysAI ANALYSIS REPORT
AI-GENERATEDBUSINESS SUMMARY
Oculis Holding AG (OCS) is a healthcare company trading on NGM with a market capitalization of $1.6B. The company currently carries a HIGH RISK rating of 26/100, flagging significant fundamental concerns. The fundamental profile shows unavailable growth data at N/A year-over-year, paired with unavailable margin data at N/A. The balance sheet shows minimal leverage with a very low debt-to-equity ratio, and the company has moderate cash runway of about 1 year.
VERDICT
OCS scores 26/100 — the fundamentals flag multiple areas of concern. Only suitable for investors with high risk tolerance and a specific catalyst thesis. This report is based on the latest available financial data and is intended as a starting point for research, not a buy or sell recommendation.
MARKET OPPORTUNITY
In the healthcare sector, cash runway and pipeline progress are critical metrics. Revenue quality depends on whether income comes from product sales, partnerships, or milestones. Oculis Holding AG operates with low insider ownership of 3.1%, which may indicate limited management alignment, which provides a signal about management's confidence in the company's direction. At a market cap of $1.6B, the company is very richly valued at over 20x price-to-sales, pricing in significant future growth at 1314.0x P/S. The combination of these factors positions OCS as a higher-risk position that requires careful due diligence before considering an investment.
REVENUE QUALITY
Revenue growth stands at N/A year-over-year, which is below the typical small-cap growth rate. Gross margins of N/A are thin and may compress further under competitive pressure. Cash runway of 15 months is adequate but should be monitored.
COMPETITIVE ADVANTAGE
Evaluating Oculis Holding AG's competitive position requires looking beyond the numbers. Insider ownership at 3.1% is relatively low, which may indicate that management's interests are less aligned with shareholders. The margin structure suggests the company operates in a competitive market where differentiation is harder to maintain. Share count management has been reasonable. Investors should research the specific sources of competitive advantage — patents, customer switching costs, scale economies, or brand — that could protect margins over time.
GROWTH THESIS
OCS presents a speculative fundamental profile that requires a specific thesis to justify investment. The elevated 1314.0x P/S ratio means significant growth is already priced in — execution must be strong to justify the premium. Key catalysts to watch include: revenue growth trajectory over the next 2-3 quarters, margin expansion or contraction, and any changes in insider buying or selling activity.
KEY RISKS
Execution risk is significant — many small-cap companies in this sector fail to transition from growth to profitability. Limited cash runway of 15 months means the company may need to raise capital, potentially diluting existing shareholders. Small-cap stocks carry inherently higher risk than large-caps, including limited analyst coverage, lower institutional ownership, and higher sensitivity to market downturns. Always conduct thorough due diligence beyond quantitative metrics.
Full AI Report available
Unlock the complete analysis including market opportunity, revenue quality, competitive moat, growth thesis, and risk assessment.
Try Free for 30 DaysReport generated: Mar 26, 2026
SCORE HISTORY
Track how this score changes over time. Start your free trial to see the full score trend chart.
RELATED STOCKS
SCORE ALERT
Get notified when OCS's score changes by 5+ points.
DATA INFO
Last updated: Mar 11, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.